We are live on
!
Find out more
ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
131 hedge funds and large institutions have $553M invested in Intra-Cellular Therapies Inc. in 2017 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 54 increasing their positions, 33 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
64% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 33
59% more call options, than puts
Call options by funds: $10.7M | Put options by funds: $6.7M
4% less funds holding
Funds holding: 137 → 131 (-6)
14% less capital invested
Capital invested by funds: $643M → $553M (-$89.9M)
23% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 26
Holders
131
Holders Change
-6
Holders Change %
-4.38%
% of All Funds
2.97%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
54
Reduced
33
Closed
26
Calls
$10.7M
Puts
$6.7M
Net Calls
+$3.98M
Net Calls Change
+$11.3M
Top Buyers
| 1 |
BlackRock
New York
|
+$10.9M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$5.3M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.08M |
| 4 |
SC
Samlyn Capital
New York
|
+$3.94M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.42M |
